Bartlett & Co. LLC Meridian Bioscience Inc Transaction History

Bartlett & Co. LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$23.75 - $31.69 $43,367 - $57,865	-1,826 Reduced 38.94%	2,863 $87,000
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $93,639 - $126,321	4,689 New	4,689 $122,000
Q4 2021 Mar 08, 2022	SELL	$17.46 - $21.61 $81,869 - $101,329	-4,689 Closed	0 $0
Q3 2021 Oct 15, 2021	SELL	$17.35 - $22.5 $2,602 - $3,375	-150 Reduced 3.1%	4,689 $90,000
Q1 2021 Apr 19, 2021	SELL	$19.76 - $29.89 $5,928 - $8,967	-300 Reduced 5.84%	4,839 $127,000
Q3 2020 Oct 20, 2020	BUY	$13.54 - $26.41 $4,061 - $7,923	300 Added 6.2%	5,139 $87,000
Q4 2017 Jan 19, 2018	SELL	$13.55 - $15.8 $12,195 - $14,220	-900 Reduced 15.68%	4,839 $68,000
Q3 2017 Oct 23, 2017	BUY	$13.45 - $14.35 $77,189 - $82,354	5,739	5,739 $82,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. LLC with notifications on news.